At Ohio State University, President Biden Introduced to the Future Potential of FLASH with Electrons
Last week, U.S. President Joe Biden visited the Ohio State University James Comprehensive Cancer Center (OSUCCC) to discuss the latest innovations in cancer research. President Biden has committed his administration’s support to “end cancer as we know it” and is expected to significantly increase government spending on new research and innovations to achieve this objective. Arnab Chakravarti, MD, Chair and Professor of Radiation Oncology and Klotz Family Chair of Cancer Research at the OSUCCC-James toured President Biden through their state-of-the-art radiation therapy department including “North America’s very first FLASH Mobetron* device. “By delivering therapy that’s “10,000 times more powerful than conventional radiotherapy”, Dr Chakravarti noted this could be a “game-changer for all cancers.”
*Ultra-High Dose Rate (UHDR) functionality for FLASH Radiotherapy is for investigational use only and is not cleared for sale by the US FDA.
Congratulations to OSUCCC’s physicians, researchers, and scientists for all their achievements in advancing cancer research and expanding access to care for patients suffering from cancer.
With our first five FLASH system installations announced, we are excited to be enabling researchers from around the world to study this potential breakthrough in advancing the therapeutic ratio for radiotherapy; and honored to be collaborating with the leading institutions and the brightest minds to make cancer treatment more effective and more accessible to patients everywhere.
Mobetron’s FLASH HDR Technology is available on both our Dermatology and IORT platforms – enabling clinicians to conduct preclinical and investigational research on an established clinical platform.